13F filer · CIK 354204 ↗
Dimensional Fund Advisors LP
You are looking at Q2 2022. See the latest, Q2 2026 →
Reported value
$278.78B
−14% on the quarter before
Positions
3,463
107 new · 156 sold out
Top 10
10.1%
of the value
Est. gain
−$46.25B
on stocks held all quarter
Est. return
−14.7%
on those stocks since Q1 2022
Positions as of Jun 30, 2022, from Dimensional Fund Advisors LP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 17% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2022. Striped tiles are options.
Largest buys
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Dimensional ETF Trust~$941.2MNew · 0.0% → 0.3%+400,000 shares
- Dimensional ETF Trust~$933.2MNew · 0.0% → 0.3%+400,000 shares
- Dimensional ETF Trust~$467.0MNew · 0.0% → 0.2%+200,000 shares
- Exxon Mobil Corp~$385.8MAdded · 0.5% → 0.8%+4,504,815 shares
- Warner Bros Discovery Inc~$260.3MNew · 0.0% → 0.1%+19,400,497 shares
- Chevron Corp New~$208.7MAdded · 0.5% → 0.6%+1,441,635 shares
- M & T Bk Corp~$154.1MAdded · 0.1% → 0.1%+966,636 shares
- Novartis Ag~$142.0MAdded · 0.1% → 0.2%+1,680,152 shares
- Tesla~$135.6MAdded · 0.4% → 0.3%+201,300 shares
- Vici Pptys Inc~$126.5MAdded · 0.1% → 0.1%+4,246,492 shares
Largest sells
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Dimensional ETF Trust~$654.2MSold out · 0.2% → 0.0%−135,000 shares
- Dimensional ETF Trust~$263.3MSold out · 0.1% → 0.0%−100,000 shares
- Colfax Corp~$251.3MSold out · 0.1% → 0.0%−6,314,756 shares
- Cerner Corp~$212.2MSold out · 0.1% → 0.0%−2,267,582 shares
- Peoples United Financial Inc~$209.4MSold out · 0.1% → 0.0%−10,473,980 shares
- Investors Bancorp Inc New~$174.9MSold out · 0.1% → 0.0%−11,713,149 shares
- Renewable Energy Group Inc~$160.7MSold out · 0.0% → 0.0%−2,648,987 shares
- Liberty Media Corp Del~$155.0MSold out · 0.0% → 0.0%−2,219,304 shares
- Yum China Hldgs Inc~$146.2MSold out · 0.0% → 0.0%−3,513,387 shares
- Ishares Inc~$134.4MSold out · 0.0% → 0.0%−2,187,200 shares
Holdings
As of Jun 30, 2022. Changes are in shares against Mar 31, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AppleCOM · shares +0.1% · price −21.7% | 2.4% | $6.68B | −$1.85B | ||||||||
| MicrosoftCOM · shares +0.9% · price −16.7% | 2.1% | $5.74B | −$1.14B | ||||||||
| AmazonCOM · shares −2.4% · price −41.4% | 0.91% | $2.54B | −$1.79B | ||||||||
| Jpmorgan Chase & CoCOM · shares +3.4% · price −17.4% | 0.81% | $2.26B | −$459.5M | ||||||||
| Exxon Mobil CorpCOM · shares +22% · price +3.7% | 0.77% | $2.16B | +$63.1M | ||||||||
| Pfizer IncCOM · shares +3.4% · price +1.2% | 0.76% | $2.11B | +$25.0M | ||||||||
| Berkshire Hathaway Inc DelCL B NEW · shares −0.03% · price −22.6% | 0.67% | $1.86B | −$545.8M | ||||||||
| Verizon Communications IncCOM · shares −1.6% · price −0.4% | 0.59% | $1.66B | −$6.4M | ||||||||
| AlphabetCAP STK CL A · shares +2.2% · price −21.6% | 0.59% | $1.66B | −$447.9M | ||||||||
| Chevron Corp NewCOM · shares +15% · price −11.1% | 0.58% | $1.62B | −$176.3M | ||||||||
| Johnson & JohnsonCOM · shares −5.1% · price +0.1% | 0.57% | $1.59B | +$2.3M | ||||||||
| AlphabetCAP STK CL C · shares +2.3% · price −21.7% | 0.56% | $1.57B | −$424.7M | ||||||||
| American TowerCOM · shares −1.3% · price +1.7% | 0.56% | $1.57B | +$26.8M | ||||||||
| Comcast Corp NewCL A · shares +0.5% · price −16.2% | 0.54% | $1.49B | −$287.0M | ||||||||
| MetaCL A · shares +8.6% · price −27.5% | 0.50% | $1.41B | −$490.8M | ||||||||
| Unitedhealth Group IncCOM · shares −8.0% · price +0.7% | 0.50% | $1.40B | +$9.7M | ||||||||
| IntelCOM · shares −2.6% · price −24.5% | 0.48% | $1.33B | −$434.0M | ||||||||
| Procter And Gamble CoCOM · shares +0.9% · price −5.9% | 0.46% | $1.27B | −$79.0M | ||||||||
| Walmart IncCOM · shares −1.2% · price −18.4% | 0.45% | $1.27B | −$284.5M | ||||||||
| PrologisCOM · shares −1.9% · price −27.1% | 0.44% | $1.22B | −$453.0M | ||||||||
| Thermo Fisher Scientific IncCOM · shares −4.4% · price −8.0% | 0.44% | $1.22B | −$106.1M | ||||||||
| Abbvie IncCOM · shares +3.1% · price −5.5% | 0.42% | $1.17B | −$66.5M | ||||||||
| ConocophillipsCOM · shares +2.5% · price −10.2% | 0.41% | $1.14B | −$125.9M | ||||||||
| AT&TCOM · shares −0.4% · price −11.3% | 0.40% | $1.13B | −$143.8M | ||||||||
| Bristol-Myers Squibb CoCOM · shares +5.3% · price +5.4% | 0.40% | $1.12B | +$54.7M | ||||||||
| Total · 3,463 positions | 100% | $278.78B | −$46.25B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2022 to Q2 2022: 3,353 stocks held throughout, down $46.25B (−14.7%).
- Eli Lilly+$113.4M+13%
- Merck & Co Inc+$68.7M+11%
- Cigna Corp New+$64.3M+10%
- Exxon Mobil Corp+$63.1M+4%
- Bristol-Myers Squibb Co+$54.7M+5%
- Berkshire Hathaway Inc Del−$545.8M−23%
- Nvidia−$604.6M−44%
- Microsoft−$1.14B−17%
- Amazon18:1 split−$1.79B−41%
- Apple−$1.85B−22%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 11 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 11, 2026 | $551.84B+15% | SEC ↗ |
| Q1 2026 | May 7, 2026 | $481.39B+1% | SEC ↗ |
| Q4 2025 | Feb 12, 2026 | $476.72B+2% | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | $466.01B+8% | SEC ↗ |
| Q2 2025 | Aug 12, 2025 | $431.92B+7% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $402.31B−3% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $416.38B+1% | SEC ↗ |
| Q3 2024 | Nov 7, 2024 | $412.28B+8% | SEC ↗ |
| Q2 2024 | Aug 9, 2024 | $382.85B+4% | SEC ↗ |
| Q1 2024 | May 10, 2024 | $369.36B+8% | SEC ↗ |
| Q4 2023 | Feb 7, 2024 | $342.47B+12% | SEC ↗ |
| Q3 2023 | Nov 9, 2023 | $304.90B−3% | SEC ↗ |
| Q2 2023 | Aug 9, 2023 | $313.77B+6% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $296.87B−12% | SEC ↗ |
| Q4 2022 | Feb 9, 2023 | $338.47B+30% | SEC ↗ |
| Q3 2022 | Nov 10, 2022 | $260.47B−7% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $278.78B−14% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $324.62B−2% | SEC ↗ |
| Q4 2021 | Feb 9, 2022 | $330.75B+7% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $310.45B−2% | SEC ↗ |
| Q2 2021 | Aug 12, 2021 | $315.84B+4% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $302.34B+9% | SEC ↗ |
| Q4 2020 | Mar 8, 2021 (amended) | $276.93B+17% | SEC ↗ |
| Q3 2020 | Nov 12, 2020 | $235.82B+4% | SEC ↗ |
| Q2 2020 | Aug 13, 2020 | $227.51B+19% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $191.95B−30% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $274.39B+7% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $257.34B−0% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $257.55B+3% | SEC ↗ |
| Q1 2019 | Aug 12, 2019 (amended) | $251.08B+14% | SEC ↗ |
| Q4 2018 | Feb 26, 2019 (amended) | $220.75B−16% | SEC ↗ |
| Q3 2018 | Nov 13, 2018 | $262.71B+5% | SEC ↗ |
| Q2 2018 | Aug 10, 2018 | $250.84B+5% | SEC ↗ |
| Q1 2018 | May 11, 2018 | $239.94B−1% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $241.23B+5% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $228.83B+6% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $216.59B+4% | SEC ↗ |
| Q1 2017 | May 12, 2017 | $209.23B+5% | SEC ↗ |
| Q4 2016 | Feb 9, 2017 | $200.21B+8% | SEC ↗ |
| Q3 2016 | Nov 10, 2016 | $185.01B+6% | SEC ↗ |
| Q2 2016 | Aug 9, 2016 | $173.79B+4% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $167.06B | SEC ↗ |